Tetramethylammonium Ion

Tetramethylammonium Ion

SCHEMBL104591

C[N+](C)(C)C.C[N+](C)(C)C.O=C([O-])[O-]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Tetramethylammonium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.50
CA4 P22748 3/20 0.43
CHRNB2 P17787 1/20 0.40
CHRNA7 P36544 1/20 0.40
CHRNA4 P43681 1/20 0.40
FAHD1 Q6P587 1/20 0.39
BBOX1 O75936 4/20 0.36
SLC22A16 Q86VW1 1/20 0.36
CPT2 P23786 1/20 0.33
CPT1A P50416 1/20 0.33
FFAR3 O14843 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetramethylammonium Ion SCHEMBL28237525 0.95 CA1 (0.46) CA1CA4CHRNB2CHRNA7CHRNA4
Tetramethylammonium Ion SCHEMBL598303 0.95
Tetramethylammonium Ion SCHEMBL28607016 0.95 CA1 (0.46) CA1CA4CHRNB2CHRNA7CHRNA4
Tetramethylammonium Ion SCHEMBL22076673 0.91 CA1 (0.43) CA1CA4CHRNB2CHRNA7CHRNA4
Tetramethylammonium Ion SCHEMBL9748322 0.88 CA1 (0.40) CA1CA4CHRNB2CHRNA7CHRNA4
Tetramethylammonium Ion SCHEMBL106975 0.86
Tetramethylammonium Ion SCHEMBL28109322 0.86 CA1 (0.73) CA1CA4CHRNB2CHRNA7CHRNA4
Tetramethylammonium Ion SCHEMBL108420 0.86
Oxalic Acid SCHEMBL36805 0.86 CA4 (0.58) CA1CA4CHRNB2CHRNA7CHRNA4
Bicarbonate SCHEMBL8013099 0.82 CA1 (0.43) CA1CA4FAHD1BBOX1SLC22A16

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 803 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12615983-B2 Methods for wet atomic layer etching of silicon dioxide TOKYO ELECTRON LIMITED (JP) 2026-04-28 US claimed
CN-121578606-A Developer composition and preparation method thereof 上海舜澳环保科技有限公司 2026-02-27 CN claimed
US-20250293039-A1 METHODS FOR WET ATOMIC LAYER ETCHING OF SILICON DIOXIDE TOKYO ELECTRON LIMITED (JP) 2025-09-18 US claimed
EP-3728367-B1 RIGID FOAMS ECONIC TECH LIMITED (GB) 2025-07-16 EP claimed
CN-119553509-A Preparation method of high-elasticity wear-resistant fabric 王正文 2025-03-04 CN claimed
CN-118561313-A Method for synthesizing copper halide-based colloid nanocrystalline at room temperature and application 浙江大学 2024-08-30 CN claimed
CN-108396327-B Equipment and method for producing tetramethyl ammonium hydroxide by continuous method 柏川新材料科技(宁波)有限公司 2024-04-09 CN claimed
CN-117380953-B Environment-friendly friction material for electromagnetic brake and preparation method thereof 成都超德创科技有限公司 2024-02-23 CN claimed
CN-117380953-A Environment-friendly friction material for electromagnetic brake and preparation method thereof 成都超德创科技有限公司 2024-01-12 CN claimed
CN-108440306-B Green production equipment and method of tetramethyl ammonium carbonate 柏川新材料科技(宁波)有限公司 2023-11-03 CN claimed
US-5002926-A Thallium-Calcium-Barium-Copper Oxide Superconductors W. R. GRACE & CO.- CONN. (US) 1991-03-26 US claimed
US-5001109-A Ceramic composition W. R. GRACE & CO.-CONN. (US) 1991-03-19 US claimed
EP-0387625-A2 Ceramic composition W.R. Grace & Co.-Conn. (US) 1990-09-19 EP claimed
EP-0355252-A2 Manufacturing method for ceramics and products thereof W.R. Grace & Co.-Conn. (US) 1990-02-28 EP claimed
CN-1038898-A CERAMIC COMPOSITION GRACE W R & CO (US) 1990-01-17 CN claimed
EP-0345663-A2 Ceramic composition W.R. Grace & Co.-Conn. (US) 1989-12-13 EP claimed
CN-1031829-A The production method of superconducting ceramics and products thereof GRACE W R & CO (US) 1989-03-22 CN claimed
EP-0306973-A2 Manufacturing method for superconducting ceramics and products thereof W.R. Grace & Co.-Conn. (US) 1989-03-15 EP claimed
US-4634509-A ELECTROLYSIS OF AQUEOUS QUATERNARY AMMONIUM CARBONATE TAMA CHEMICAL CO., LTD. (JP) 1987-01-06 US claimed
US-3956171-A Process for preparing stable positively charged alumina coated silica sols and product thereof E. I. DU PONT DE NEMOURS AND COMPANY (US) 1976-05-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12615983-B2 Methods for wet atomic layer etching of silicon dioxide SIGLEC7, SIGLEC9, ASH2L CA1 5/4885CA4 45/4885CHRNB2 2157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.